Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 2
2012 3
2013 10
2014 12
2015 6
2016 6
2017 6
2018 2
2019 2
2020 1
2021 3
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

48 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean ilaria march (1 results)?
What Are the Biomarkers for Immunotherapy in SCLC?
Longo V, Catino A, Montrone M, Pizzutilo P, Annese T, Pesola F, Marech I, Cassiano S, Ribatti D, Galetta D. Longo V, et al. Among authors: marech i. Int J Mol Sci. 2021 Oct 15;22(20):11123. doi: 10.3390/ijms222011123. Int J Mol Sci. 2021. PMID: 34681779 Free PMC article. Review.
An evaluation of masitinib for treating systemic mastocytosis.
Laforgia M, Marech I, Nardulli P, Calabrò C, Gadaleta CD, Ranieri G. Laforgia M, et al. Among authors: marech i. Expert Opin Pharmacother. 2019 Sep;20(13):1539-1550. doi: 10.1080/14656566.2019.1645121. Epub 2019 Aug 5. Expert Opin Pharmacother. 2019. PMID: 31381378 Review.
In vivo model for mastocytosis: A comparative review.
Ranieri G, Marech I, Pantaleo M, Piccinno M, Roncetti M, Mutinati M, Rizzo A, Gadaleta CD, Introna M, Patruno R, Sciorsci RL. Ranieri G, et al. Among authors: marech i. Crit Rev Oncol Hematol. 2015 Mar;93(3):159-69. doi: 10.1016/j.critrevonc.2014.10.010. Epub 2014 Oct 31. Crit Rev Oncol Hematol. 2015. PMID: 25465741 Review.
Predictive factors to targeted treatment in gastrointestinal carcinomas.
Silvestris N, Marech I, Brunetti AE, Azzariti A, Numico G, Cicero G, Delcuratolo S, De Luca R, Burz C, Lorusso V. Silvestris N, et al. Among authors: marech i. Cancer Biomark. 2014;14(2-3):151-62. doi: 10.3233/CBM-130327. Cancer Biomark. 2014. PMID: 24878816 Review.
Dasatinib: an anti-tumour agent via Src inhibition.
Gnoni A, Marech I, Silvestris N, Vacca A, Lorusso V. Gnoni A, et al. Among authors: marech i. Curr Drug Targets. 2011 Apr;12(4):563-78. doi: 10.2174/138945011794751591. Curr Drug Targets. 2011. PMID: 21226671 Review.
48 results